美容醫療市場：按程序和地區分類

Aesthetic Medicine Market, By Procedure and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年，美容醫療市場規模估計為2,220.3億美元，預計到2032年將達到5,728.6億美元，2025年至2032年的年複合成長率（CAGR）為14.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	2220.3億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年年複合成長率：	14.50%	2032年價值預測	5728.6億美元

美容醫學是現代醫學的一個分支，專注於透過治療皺紋、皮膚鬆弛、皮膚變色、痣、疤痕、黃褐斑、脂肪團、多餘脂肪、蜘蛛蜘蛛網狀靜脈曲張、多餘毛髮等來改變美容外觀。因此，隨著人們越來越注重自己的整體外觀，全球對美容醫學的需求也迅速成長。

市場動態：

老年人口的增加、微創治療的採用率的提高、對美容治療的需求增加以及人們對整體外觀和美容手術的認知不斷提高是預計在預測期內推動全球美容醫學市場成長的關鍵因素。

例如，2023年6月，BoomerangFX宣布與醫療技術先驅DrFirst合作，為客戶提供一個整合的藥物管理平台，最大限度地提高臨床工作流程和病人參與。 BoomerangFX已與DrFirst合作，為北美的美容醫療診所推出電子處方。

然而，整容手術成本高、社會恥辱和報銷不足等因素預計將阻礙全球美容醫療市場的成長。

本研究的主要特點

本報告對全球美容醫療市場進行了詳細分析，並以 2024 年為基準年，展示了 2025 年至 2032 年預測期內的市場規模和年複合成長率（CAGR%）。
它揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
該報告涵蓋了全球美容醫療市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、主要亮點、財務表現和策略。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球美容醫學市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
可以透過用於分析全球美容醫學市場的各種策略矩陣來促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 222.03 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.50%	2032 Value Projection:	USD 572.86 Bn

Aesthetic medicine is a branch of modern medicine that focuses on altering cosmetic appearance through the treatment of conditions such as wrinkles, skin laxity, skin discoloration, moles, scars, liver spots, cellulite, excess fat, spider veins, and/or unwanted hair, among others. Thus, with the increasing awareness among people about overall appearance, the demand for aesthetic medicine is also increasing with a rapid pace, worldwide.

Market Dynamics:

Growing geriatric population, increasing adoption of minimally invasive treatments, high demand for aesthetic treatments, and rising awareness among people about overall appearance or aesthetic procedures are major factors expected to boost the growth of the global aesthetic medicine market during the forecast period.

For instance, in June 2023, BoomerangFX announced that it has partnered with health technology pioneer DrFirst to offer clients the unified medication management platform to maximize clinical workflows and patient engagement. BoomerangFX partnered with DrFirst to launch e-prescribing for aesthetic medicine practices across North America.

However, factors such as high cost of aesthetic procedures, social stigma, and poor reimbursement are expected to hamper the growth of the global aesthetic medicine market.

Key features of the study:

This report provides in-depth analysis of the global aesthetic medicine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global aesthetic medicine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Hologic, Inc. (Cynosure), Abbvie (Allergan), Solta Medical, Candela Medical, Merz Pharma GMBH, Revance Therapeutics Inc., Lumenis, Alma Laser, Galderma Pharmaceuticals S.A., and Johnson & Johnson Services, Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global aesthetic medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aesthetic medicine market.

Detailed Segmentation:

Global Aesthetic Medicine Market , By Procedure:
- Invasive Procedures
- Breast Augmentation
- Liposuction
- Nose Reshaping
- Eyelid Surgery
- Tummy Tuck
- Others
- Non-invasive Procedures
- Botox Injections
- Soft Tissue Fillers
- Chemical Peel
- Laser Hair Removal
- Microdermabrasion
- Others
Global Aesthetic Medicine Market By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Alma Laser
- Hologic, Inc. (Cynosure)
- Abbvie (Allergan)
- Solta Medical
- Candela Medical
- Merz Pharma GMBH
- Revance Therapeutics Inc.
- Lumenis
- Galderma Pharmaceuticals S.A.
- Johnson & Johnson Services, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Procedure
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- High demand for aesthetic treatments
- High cost of aesthetic procedure
- Increasing awareness among people
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Aesthetic Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Aesthetic Medicine Market, By Procedure, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Invasive Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Breast Augmentation
Liposuction
Nose Reshaping
Eyelid Surgery
Tummy Tuck
Others
Non-Invasive Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Botox Injections
Soft Tissue Fillers
Chemical Peel
Laser Hair Removal
Microdermabrasion
Others

6. Global Aesthetic Medicine Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)

7. Competitive Landscape

Alma Laser
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic, Inc. (Cynosure)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbvie (Allergan)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Solta Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Candela Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merz Pharma GMBH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Revance Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lumenis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Galderma Pharmaceuticals S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views